Total amount: € 0,00
Official Journal of the , the International Union of Phlebology and the
Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,899
Online ISSN 1827-1839
Makita T., Tanaka A., Nakano T. *, Nakajima K. *, Numano F.
From the Third Department of Internal Medicine, Tokyo Medical and Dental University, Tokyo, Japan
* Japan Immunoresearch Laboratories, Takasaki City, Japan
Background. Two studies were conducted to determine the importance of glycation in the acceleration of low density lipoprotein (LDL) uptake by macrophages in patients with diabetes mellitus.
Methods. Healthy individuals (n=6) and non-insulindependent diabetic patients (n=6) were studied. LDL was separated by sequential ultracentrifugation. Macrophages were collected from the abdominal cavity of ICR-mice and incubated in a medium containing [14C] oleate. In Study 1, LDL from diabetic patients (DM-LDL) and control LDL were then incubated with this medium. The uptake of DM-LDL by macrophages was compared with that of control LDL by measuring the [14c] content of the synthesized cholesteryl ester. In Study 2, glycated LDL was prepared by glycating LDL from 6 healthy individuals in vitro. The uptake of native LDL by macrophages was compared with that of glycated LDL using the same method as in Study 1.
Results. In Study 1, the uptake of DM-LDL (median:1,405; range: 985-2269 dpm) was significantly higher than that of control LDL (median: 1,095; range: 990-1104 dpm, p<0.05). In Study 2, the uptake of glycated LDL (median: 1,556; range: 889-2837 dpm) was significantly higher than that of native LDL (median: 1,176; range: 789-2098 dpm, p<0.05).
Conclusions. The results indicate that the greater uptake of DM-LDL than that of control LDL may be attributed to glycation of LDL caused by hyperglycemia in diabetic patients. Glycation of LDL by hyperglycemia may be one cause of the accelerated atherogenesis in diabetic patients.